Literature DB >> 8443981

V delta 2+ gamma delta T lymphocytes are cytotoxic to the MCF 7 breast carcinoma cell line and can be detected among the T cells that infiltrate breast tumors.

I Bank1, M Book, M Huszar, Y Baram, I Schnirer, H Brenner.   

Abstract

In order to study the potential role of gamma delta T lymphocytes in cytotoxicity against breast carcinoma cells, normal peripheral blood gamma delta cells were isolated and triggered with an alloantigenic lymphoblastoid B cell line and recombinant interleukin-2 and cloned. The clones expressed a CD3+V gamma 9+V delta 2+CD4-CD8- (or CD8+) phenotype. Five clones were cytotoxic to the Molt 4 T cell leukemia, but not to the alloantigen, whereas one clone lysed the alloantigen, but not the Molt 4 line. Clones that were cytotoxic to Molt 4 were either spontaneously cytotoxic against MCF 7 breast carcinoma cells or could be induced to kill MCF 7 cells by monoclonal antibodies specific for the gamma delta T cell receptor. In situ staining demonstrated that V delta 2+ as well as other subsets of gamma delta T cells can be detected in the lymphocytic infiltrate within breast carcinomas. These data showing that V delta 2+ T cells can recognize and kill cells of breast carcinoma lineage in vitro, and that cells expressing V delta 2 genes in their T cell receptor structure can be detected in the tumor, suggest that further studies of the nature of the interactions between V delta 2 T cells and breast carcinoma cells are warranted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443981     DOI: 10.1006/clin.1993.1040

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  10 in total

1.  Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.

Authors:  Amudhan Maniar; Xiaoyu Zhang; Wei Lin; Brian R Gastman; C David Pauza; Scott E Strome; Andrei I Chapoval
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

Review 2.  Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public.

Authors:  C David Pauza; Cristiana Cairo
Journal:  Cell Immunol       Date:  2015-03-04       Impact factor: 4.868

3.  Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.

Authors:  Benjamin H Beck; Hyung-Gyoon Kim; Hyunki Kim; Sharon Samuel; Zhiyong Liu; Robin Shrestha; Hilary Haines; Kurt Zinn; Richard D Lopez
Journal:  Breast Cancer Res Treat       Date:  2009-09-18       Impact factor: 4.872

4.  Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors.

Authors:  Reeva Aggarwal; Jingwei Lu; Suman Kanji; Manjusri Das; Matthew Joseph; Maryam B Lustberg; Alo Ray; Vincent J Pompili; Charles L Shapiro; Hiranmoy Das
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

5.  Impact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.

Authors:  Hiranmoy Das; Zhihui Wang; M Khalid Khan Niazi; Reeva Aggarwal; Jingwei Lu; Suman Kanji; Manjusri Das; Matthew Joseph; Metin Gurcan; Vittorio Cristini
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

6.  Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas.

Authors:  Jose Villacorta Hidalgo; Peter Bronsert; Marzenna Orlowska-Volk; Liliana B Díaz; Elmar Stickeler; Martin Werner; Annette Schmitt-Graeff; Gian Kayser; Miroslav Malkovsky; Paul Fisch
Journal:  Front Immunol       Date:  2014-12-10       Impact factor: 7.561

7.  Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner.

Authors:  Daniel W Fowler; John Copier; Angus G Dalgleish; Mark D Bodman-Smith
Journal:  Cancer Immunol Immunother       Date:  2017-05-13       Impact factor: 6.968

8.  Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.

Authors:  Gabrielle M Siegers; Indrani Dutta; Eun Young Kang; Jing Huang; Martin Köbel; Lynne-Marie Postovit
Journal:  Front Immunol       Date:  2020-06-19       Impact factor: 7.561

9.  Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms.

Authors:  Zhiqiao Zhang; Jing Li; Tingshan He; Jianqiang Ding
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

10.  ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.

Authors:  Jiazhou Liu; Yuxian Wei; Yushen Wu; Jie Li; Jiazheng Sun; Guosheng Ren; Hongzhong Li
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.